Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06029218
Status:
RECRUITING
Last Update Posted:
2023-09-15
First Post:
2023-07-25
Brief Title:
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Sponsor:
Centre Antoine Lacassagne
Organization:
Centre Antoine Lacassagne
Study Overview
Official Title:
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
P1V2
Brief Summary:
Thanks to the intrinsic qualities of the proton beam proton therapy will reduce adverse effects of irradiation The ProteusOne is the latest generation of proton therapy equipment enabling the Centre Antoine Lacassagne to expand its range of treatments by carrying out new proton therapy treatments It has an innovative compact isocentric rotating head Gantry that allows the radiation beam to be directed at different angles around the patient In some cases two beams are used to treat tumours and by convention both beams are delivered during the same session However it is necessary to position the patient before each beam which is time-consuming because 2 beams have to be positioned very precisely each day The aim of this study is therefore to assess the toxicity of proton therapy delivered by a single daily beam compared with proton therapy delivered by two daily beams which is the conventional technique
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None